District Court, E.D. Pennsylvania July 24, 2020, 2:02-cv-02964 (UNITED STATES OF AMERICA ex rel. YOASH GOHIL v. AVENTIS PHARMACEUTICALS, INC.)

Also known as

United States · · · 24-07-2020

IN THE UNITED STATES DISTRICT COURT

FOR THE EASTERN DISTRICT OF PENNSYLVANIA

UNITED STATES ex rel. :

YOASH GOHIL, :

Plaintiff/Relator. : CIVIL ACTION

: No. 02-2964

v. :

:

SANOFI U.S. SERVICES INC. :

et al.,

Defendants. :

July 21, 2020 Anita B. Brody, J.

MEMORANDUM

Relator Yoash Gohil brings this lawsuit against Aventis, a large

pharmaceutical company and his former employer.1 Among other things, Gohil

alleges that Aventis violated the False Claims Act (“FCA”) by engaging in a

variety of nationwide kickback schemes between 1996-2004 to induce doctors to

prescribe—and then request government reimbursement for— Aventis’s cancer

drug, Taxotere. One of the alleged schemes involves Aventis’s reimbursement-

assistance program, the “Providing Access to Cancer Therapy Program”

1 As a result of several mergers, the Defendant has gone by several different names

throughout the relevant period of this lawsuit. For ease of reference, the Court

refers to Defendant solely as “Aventis.”

(“PACT”).2 PACT helped doctors submit reimbursement claims for Taxotere,

handled administrative appeals when those claims were denied, and gave doctors

free replacement vials of the drug when appeals were unsuccessful. Gohil

maintains that these services were kickbacks that led to the submission of “false or

fraudulent claims,” in violation of the False Claims Act.

In June and July of 2019, both parties filed cross-motions for summary

judgment focused on whether PACT’s services were illegal kickbacks that gave

rise to FCA liability. On March 4, 2020, I denied both motions. This

memorandum explains that denial.3

2 Throughout the relevant time period, Aventis hired third-party companies to

operate the PACT Program. In this opinion, references to “PACT” should be taken

to mean both Aventis and the companies it used to run PACT.

3 Gohil also alleges that Aventis entered into a variety of separate kickback

schemes to promote Taxotere, unrelated to the PACT Program.

Read the full text

This document is published by courtlistener.com.

Moonlit adds the citation network, article-level links and cross-references, which are available to search for free.